Search the Newsreel

Hindustan Aeronautics Limited (NSE:HAL) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Hindustan Aeronautics shares gain 11% in a month; all eyes on Q1 result amid easing engine supply issues

Hindustan Aeronautics Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Hindustan Aeronautics shares jump over 5% on Goldman Sachs upgrade; Check key factors behind it

Hindustan Aeronautics Stock Leads 3 Indian Shares Backed By Defense And Housing Demand

NAUT|Nautilus Biotechnology Inc|Price:0.977|Chg%:-0.053

Nautilus Biotechnology Inc (NAUT) closed at $0.977, experiencing a 5.15% decline. Analysts rate NAUT as a "Strong Buy" with a target price indicating a 284.62% upside. The company is a development-stage life sciences firm focused on proteomics, aiming to democratize access to the human …

Nautilus Biotechnology, Inc. Revenue Breakdown – NASDAQ:NAUT

The article provides a basic financial overview page for Nautilus Biotechnology, Inc. (NASDAQ:NAUT) on TradingView. It indicates that the market is closed, with no trades, and points to various financial data sections such as statements, statistics, dividends, earnings, and segments. The content primarily outlines …

Nautilus Biotechnology Inc (NAUT) Q2 2026 Earnings Call Highlights: Strategic Shifts and ...

Nautilus Biotechnology Inc (NAUT) has announced a strategic shift of R&D resources towards its proteoform application, showing strong customer interest and initial revenue from collaborations. While facing a net loss of $14.5 million and needing further fundraising, the company highlights its unique proteoform assay …

Nautilus Biotechnology, Inc. 2026: Revenue $190K, EPS ($0.11) — 10-Q Summary

Nautilus Biotechnology, Inc. (NAUT) reported its 2026 quarterly results, generating $190K in revenue and a net loss of ($14.47M), or ($0.11) diluted EPS, showing modest improvement from the previous year. The company began Early Access service sales, reallocated resources to accelerate proteoform assays development, …

Nautilus Biotechnology Inc (NAUT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Nautilus Biotechnology Inc (NAUT), including its current stock price, market cap, and technical indicator ratings. It details the performance of various indicators like MACD, RSI, and Moving Averages, which generally suggest a "Sell" signal for the stock. …

Earnings call transcript: Nautilus Biotechnology beats Q2 2026 EPS forecast

Nautilus Biotechnology (NAUT) reported a smaller-than-expected Q2 2026 loss, beating EPS forecasts by $0.04 and generating $0.2 million in revenue, primarily from grant funding. The company is strategically shifting R&D focus from its Broadscale program to proteoform development due to strong customer demand and …

Nautilus Biotechnology Reports Second Quarter 2026 Financial Results

Nautilus Biotechnology (NASDAQ: NAUT) reported its second-quarter 2026 financial results, including its first-ever revenues driven by a grant from the Michael J. Fox Foundation and an early access program. The company is reallocating resources to accelerate its proteoform applications due to strong customer enthusiasm, …

Nautilus Biotechnology (NASDAQ: NAUT) posts $29.2M loss but holds $129.2M in cash and investments

Nautilus Biotechnology (NASDAQ: NAUT) shifts roadmap after Q2 2026 results

Price to earnings forward of Nautilus Biotechnology, Inc. – NASDAQ:NAUT

This article provides financial information for Nautilus Biotechnology, Inc. (NASDAQ: NAUT), specifically focusing on its forward price-to-earnings ratio. The content is presented within the context of TradingView's platform, offering financial data and market insights for the company.

Nautilus Biotechnology Inc (NAUT) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for Nautilus Biotechnology Inc (NAUT), covering operating, investing, and financing activities. It presents financial data from FY2020Q1 to FY2026Q1, highlighting trends in net income, capital expenditures, and free cash flow. The company's operating …

Nautilus Biotechnology Inc (NAUT) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Nautilus Biotechnology Inc (NAUT) focusing on its dividend and stock split history. It notes that the company has not distributed any dividends over the past five years. The page also presents current stock performance data, including its market …

NAUT Balance Sheet

This page provides the quarterly and annual balance sheets for Nautilus Biotechnology Inc (NAUT), allowing users to assess its financial health, analyze fundamentals, and calculate key financial ratios. It includes detailed breakdowns of assets, liabilities, and shareholders' equity over several quarters and years. The …

Nautilus Biotechnology (NAUT) to Post Earnings on Tuesday

Hindustan Aeronautics Limited (HAL) Share Price Forecast: 7-Year Backlog, Tejas Risk, Aug 7 Earnings